Dallas, TX: ReportsandReports announce Actelion Ltd: PharmaVitae Profile Market Research Report in its Store.
Browse complete Report at: http://www.reportsandreports.com/reports/9347-actelion-ltd-pharmavitae-profile.html
This analysis examines the historical and forecast performance for Actelion in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
• Benchmark Actelion’s performance against key rivals in the ethical pharmaceutical sector
• Learn how Actelion’s focus on a novel pathophysiological pathway has rapidly transformed it from a startup biotech into a billion dollar company
• Evaluate the impressive pipeline potential that is set to drive Actelion’s future commercial focus
• CHAPTER 1 ABOUT THIS PROFILE 2
• Executive summary 2
Quarterly news update 2
Company introduction 2
Company sales 2
Company financials 2
Key products and competitors 3
Data sourcing 3
Sales data 3
Analyst consensus 3
• CHAPTER 2 EXECUTIVE SUMMARY 4
• Key findings 4
Prescription pharmaceutical sales performance, 2001-13 5
Financial performance, 2001-13 6
Actelion: PharmaVitae forecasts at a glance 7
Strategic insight 8
Rapid evolution of a successful biotech company 8
Extensive clinical development program can breathe new life into Tracleer 10
Novel CNS drug almorexant offers significant growth potential beyond Actelion’s specialist disease 14
Innovative pipeline efforts draws Big Pharma attention 15
SWOT analysis 17
Strengths 17
Weaknesses 19
Opportunities 20
Threats 21
• CHAPTER 3 QUARTERLY NEWS UPDATE 25
• Product developments 25
Deals and alliances 25
Product deals 25
Company announcements 26
Future product milestones 26
• CHAPTER 4 COMPANY INTRODUCTION 27
• Key findings 27
Background 28
Key corporate developments 28
M&A history 30
Axovan 30
CoTherix 30
• CHAPTER 5 COMPANY SALES 31
• Key findings 31
Prescription pharmaceutical sales and growth rate analysis, 2001-13 32
Historical analysis 33
Forecast analysis 33
Product analysis 35
Product analysis, 2001-07 36
Growth drivers 37
Product analysis, 2007-13 38
Growth drivers 39
Therapy area analysis 41
Therapy area analysis, 2001-07 42
Therapy area analysis, 2007-13 43
Therapy area focus, 2001-13 44
Geographic analysis 45
Geographic analysis, 2001-07 46
Geographic analysis, 2007-13 47
Geographic focus, 2001-13 49
Launch/core/expiry analysis 50
Explanation of launch/core/expiry analysis 50
Launch analysis, 2007-13 51
Core analysis, 2007-13 52
Launch/core/expiry configuration, 2007-13 53
Molecule type analysis 54
Externalization analysis 55
Externalization analysis, 2001-07 56
Externalization analysis, 2007-13 57
• CHAPTER 6 COMPANY FINANCIALS 58
• Key findings 58
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2001-07 59
Financial statements, 2001-07 60
Profit and loss account, 2001-07 60
Balance sheet, 2001-07 61
Operating costs and profit analysis 63
Operating costs and profit analysis, 2001-07 64
Operating cost ratio and profit margin analysis, 2001-07 65
Operating cost ratio and profit margin analysis, 2007-13 66
Operating costs and profit analysis, 2007-13 68
Return on capital employed analysis 69
Capital employed analysis, 2001-07 70
Return on capital employed (RoCE) analysis, 2001-07 72
Market capitalization analysis 74
Market capitalization analysis, 2001-07 74
Total shareholder returns analysis, 2001-07 76
• CHAPTER 7 KEY PRODUCTS AND COMPETITORS 78
• Key findings 78
Overview 79
Cardiovascular 80
Tracleer 80
Overview 82
Sales forecast 83
Ventavis 97
Overview 98
Sales forecast 99
Clazosentan 102
Overview 103
Sales forecast 104
Central nervous system 107
Almorexant 107
Overview 108
Sales forecast 109
Endocrine, metabolic & genetic disorders 112
Zavesca 112
Overview 113
Sales forecast 114
• CHAPTER 8 APPENDIX 116
• R&D pipeline 116
References 117
Abbreviations 117
Exchange rates 119
ABBREVIATIONS
Browse all : Healthcare Market Research Reports
http://www.reportsandreports.com/cat/healthcare-market-research.html
Browse all : Datamonitor Market Research Reports
http://www.reportsandreports.com/Publisher/datamonitor-market-research.html-market-research.html
Browse all Newly Published Market Research Reports
http://www.reportsandreports.com/LatestReport.aspx
Original Source : PharmaVitae Market
http://www.reportsandreports.com/reports/9347-actelion-ltd-pharmavitae-profile.html
Buy Now : Market Research Report
http://www.reportsandreports.com/
Related Reports:
Actelion Pharmaceuticals Ltd-Deals & Alliances Report
http://www.reportsandreports.com/reports/31725-actelion-pharmaceuticals-ltd-deals-alliances-report.html
Actelion Pharmaceuticals Ltd-Detailed Product Pipeline
http://www.reportsandreports.com/reports/28907-actelion-pharmaceuticals-ltd-detailed-product-pipeline.html
Actelion Pharmaceuticals Ltd-Company Report
http://www.reportsandreports.com/reports/4562-actelion-pharmaceuticals-ltd-company-report.html
Actelion Ltd – SWOT Analysis
http://www.reportsandreports.com/reports/2467-actelion-ltd-swot-analysis.html
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile
http://www.reportsandreports.com/reports/8200-f-hoffmann-la-roche-ltd-pharmavitae-profile.html
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
